← Leaderboards
Sunita Gulati
Boston Medical Center
$3,378,912
Attributed
$5,222,697
Total exposure
4
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $950.4K · FY2005–19$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$5,222,697 · 4
By mechanism
R01$3,332,147 · 2
R33$1,434,245 · 1
R21$456,305 · 1
Top collaborators
- Sanjay Ram5 shared
- Peter A. Rice4 shared
Others in their field
Top investigators on “Neisseria Gonorrhoeae”
- H. Steven Seifert · Northwestern University$22,507,026
- Sanjay Ram · Univ Of Massachusetts Med Sch Worcester$17,986,057
- Jay B Jackson · Johns Hopkins University$17,529,470
- Peter A. Rice · Univ Of Massachusetts Med Sch Worcester$16,816,488
- Cynthia Nau Cornelissen · Virginia Commonwealth University$15,969,202
- William Maurice Shafer · Veterans Health Administration$14,813,541
Research focus
Neisseria GonorrhoeaeIn VivoPeptidesLipooligosaccharideComplementInfectionVaginaStructureMouse ModelSuperbugGonorrheaImmuneResistant StrainChronic Pelvic PainPelvic Inflammatory DiseaseComplement InactivatorsNeutrophilComplement 4b-Binding ProteinComplement Factor HInfertilityEctopic PregnancyCeftriaxoneAntibioticsResistance
Grant awards (14)
Sialic acid analogs as novel immunotherapeutics against multidrug-resistant gonorrhea$465,374
R33 · FY2019 · AI
Sialic acid analogs as novel immunotherapeutics against multidrug-resistant gonorrhea$467,677
R33 · FY2018 · AI
Lipooligosaccharide mimitope vaccines against Neisseria gonorrhoeae$449,255
R01 · FY2018 · AI
Sialic acid analogs as novel immunotherapeutics against multidrug-resistant gonorrhea$501,194
R33 · FY2017 · AI
Lipooligosaccharide mimitope vaccines against Neisseria gonorrhoeae$449,255
R01 · FY2017 · AI
Lipooligosaccharide mimitope vaccines against Neisseria gonorrhoeae$449,255
R01 · FY2016 · AI
Sialic acid analogs as novel immunotherapeutics against multidrug-resistant gonorrhea$198,699
R21 · FY2016 · AI
Lipooligosaccharide mimitope vaccines against Neisseria gonorrhoeae$449,255
R01 · FY2015 · AI
Sialic acid analogs as novel immunotherapeutics against multidrug-resistant gonorrhea$257,606
R21 · FY2015 · AI
Mimotopes of gonococcal oligosaccharides for vaccination$302,304
R01 · FY2008 · AI · contact PI
Mimotopes of gonococcal oligosaccharides for vaccination$308,159
R01 · FY2007 · AI · contact PI
Mimotopes of gonococcal oligosaccharides for vaccination$317,363
R01 · FY2006 · AI · contact PI
Mimotopes of gonococcal oligosaccharides for vaccination$285,301
R01 · FY2005 · AI
Mimotopes of gonococcal oligosaccharides for vaccination$322,000
R01 · FY2004 · AI